Frazier Life Sciences Acquisition Corp. II (FLSC) income statement
FLSCNasdaqBlank ChecksFiscal year ends December 31
Last filing: 10-Q on Nov 17, 2026
$10.05−0.02 (-0.20%)
Close on Nov 18, 2026Market cap –P/E –Yield –
Frazier Life Sciences Acquisition Corp. II income statement
AnnualQuarterlyTTM
This company has not reported income statement data in its XBRL filings.
Ratios
Latest available, balances at Sep 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY
- –
Financial strength
- Current ratio
- 0.31
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 31.0%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?